Improved anti-malarial parasite efficacy with heparin-artemisinin nanoemulsions
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Malaria Research and Control · Research on Leishmaniasis Studies · Aquaculture disease management and microbiota
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (82)
Show source-provided references
1. Malaria World, World Malaria Report 2023. https://malariaworld.org/blogs/world-malaria-report-2023 (accessed April 23, 2024).
2. Malaria10.1038/nrdp.2017.50 ↗
3. Treatment and prevention of malaria in children10.1016/S2352-4642(20)30127-9 ↗
4. Effectiveness of pyronaridine-artesunate against Plasmodium malariae, Plasmodium ovale spp, and mixed-Plasmodium infections: a post-hoc analysis of the CANTAM-Pyramax trial10.1016/S2666-5247(22)00092-1 ↗
5. The birth of artemisinin10.1016/j.pharmthera.2020.107658 ↗
6. Advances in the research on the targets of anti-malaria actions of artemisinin10.1016/j.pharmthera.2020.107697 ↗
7. Profiling the Antimalarial Mechanism of Artemisinin by Identifying Crucial Target Proteins10.1016/j.eng.2023.06.001 ↗
8. Molecular Mechanisms of Drug Resistance in Plasmodium falciparum Malaria10.1146/annurev-micro-020518-115546 ↗
9. The treatment of malaria10.1056/NEJM199609123351107 ↗
10. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study10.1016/S1473-3099(12)70181-0 ↗
11. Plasmodium falciparum resistance to artemisinin-based combination therapies10.1016/j.mib.2022.102193 ↗
12. Qinghaosu (artemisinin): chemistry and pharmacology10.1038/aps.2012.104 ↗
13. Engineering precision nanoparticles for drug delivery10.1038/s41573-020-0090-8 ↗
14. Research progress on self-assembled nanodrug delivery systems10.1039/D1TB02470A ↗
15. Nanoemulsions in drug delivery: formulation to medical application10.2217/nnm-2018-0088 ↗
16. Advances in edible nanoemulsions: Digestion, bioavailability, and potential toxicity10.1016/j.plipres.2020.101081 ↗
17. Nanoemulsions: formation, properties and applications10.1039/C5SM02958A ↗
18. Current Applications of Nanoemulsions in Cancer Therapeutics10.3390/nano9060821 ↗
19. A critical review of the novelties in the development of intravenous nanoemulsions10.1016/j.ejpb.2023.08.009 ↗
20. Lipid Nanoparticle Technology for Delivering Biologically Active Fatty Acids and Monoglycerides10.3390/ijms22189664 ↗
21. Clotrimazole nanoemulsion for malaria chemotherapy. Part I: Preformulation studies, formulation design and physicochemical evaluation
22. Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine
23. Arteether nanoemulsion for enhanced efficacy against Plasmodium yoelii nigeriensis malaria: An approach by enhanced bioavailability10.1016/j.colsurfb.2014.12.052 ↗
24. Malaria: Biology and Disease10.1016/j.cell.2016.07.055 ↗
25. A heparin-binding protein of Plasmodium berghei is associated with merozoite invasion of erythrocytes10.1186/s13071-023-05896-w ↗
26. Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites10.1182/blood-2009-09-243725 ↗
27. Plasmodium falciparum BAEBL binds to heparan sulfate proteoglycans on the human erythrocyte surface10.1074/jbc.M109.021576 ↗
28. Proteomic analysis of Plasmodium falciparum schizonts reveals heparin-binding merozoite proteins10.1021/pr400038j ↗
29. Heparin-Coated Dendronized Hyperbranched Polymers for Antimalarial Targeted Delivery10.1021/acsapm.2c01553 ↗
30. Red Blood Cells Oligosaccharides as Targets for Plasmodium Invasion10.3390/biom12111669 ↗
31. Repurposing Heparin as Antimalarial: Evaluation of Multiple Modifications Toward In Vivo Application10.3390/pharmaceutics12090825 ↗
32. Identification of Heparin Modifications and Polysaccharide Inhibitors of Plasmodium falciparum Merozoite Invasion That Have Potential for Novel Drug Development10.1128/AAC.00709-17 ↗
33. Enhanced Antimalarial Efficacy Obtained by Targeted Delivery of Artemisinin in Heparin-Coated Magnetic Hollow Mesoporous Nanoparticles10.1021/acsami.0c20070 ↗
34. Highly Sensitive and Rapid Characterization of the Development of Synchronized Blood Stage Malaria Parasites Via Magneto-Optical Hemozoin Quantification10.3390/biom9100579 ↗
35. Magnetically targeted co-delivery of hydrophilic and hydrophobic drugs with hollow mesoporous ferrite nanoparticles10.1039/C8RA02343C ↗
36. Surface design of magnetic nanoparticles for stimuli-responsive cancer imaging and therapy10.1016/j.biomaterials.2017.05.013 ↗
37. Target-specific cellular uptake of taxol-loaded heparin-PEG-folate nanoparticles10.1021/bm101013s ↗
38. DSPE-PEG Modification of α-Conotoxin TxID10.3390/md17060342 ↗
39. Supported lipid bilayer coatings: Fabrication, bioconjugation, and diagnostic applications
40. Efficient encapsulation of a water-soluble corticosteroid in biodegradable nanoparticles
41. Preparation and characterization of a nanoparticulate formulation composed of PEG-PLA and PLA as anti-inflammatory agents
42. Artesunate-heparin conjugate based nanocapsules with improved pharmacokinetics to combat malaria
43. Formulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complex10.1248/cpb.59.321 ↗
44. Elucidating Structural Configuration of Lipid Assemblies for mRNA Delivery Systems10.1021/acsnano.4c00587 ↗
45. Liposomes of dimeric artesunate phospholipid: A combination of dimerization and self-assembly to combat malaria10.1016/j.biomaterials.2018.02.026 ↗
46. Long circulatory liposomal maduramicin inhibits the growth of Plasmodium falciparum blood stages in culture and cures murine models of experimental malaria10.1039/C8NR02442A ↗
47. The chemotherapy of rodent malaria, XXVIII. The development of resistance to mefloquine (WR 142,490)10.1080/00034983.1977.11687207 ↗
48. Development of docetaxel-loaded intravenous formulation, Nanoxel-PMTM using polymer-based delivery system10.1016/j.jconrel.2011.06.012 ↗
49. Reduced in vivo toxicity of doxorubicin by encapsulation in cholesterol-containing self-assembled nanoparticles10.1016/j.phrs.2016.03.006 ↗
50. Drug-interactive mPEG- b -PLA-Phe (Boc) micelles enhance the tolerance and anti-tumor efficacy of docetaxel10.1080/10717544.2020.1718245 ↗
51. Nano-emulsions10.1016/j.cocis.2005.06.004 ↗
52. Chapter 1 - General Aspects of Nanoemulsions and Their Formulation
53. Colloidal stability of polymeric nanoparticles in biological fluids10.1007/s11051-012-0920-7 ↗
54. Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations10.1186/s12951-021-00946-w ↗
55. Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery10.1016/j.jconrel.2016.01.034 ↗
56. Size-dependent, stochastic nature of lipid exchange between nano-vesicles and model membranes10.1039/C6NR03817D ↗
57. Hydrodynamic Propulsion of Liposomes Electrostatically Attracted to a Lipid Membrane Reveals Size-Dependent Conformational Changes10.1021/acsnano.6b04572 ↗
58. Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective10.1016/j.addr.2007.09.010 ↗
59. Controlling molecular self-assembly of inverse-phosphocholine lipids at oxide interfaces with divalent cations
60. Soy Lecithin-Derived Liposomal Delivery Systems: Surface Modification and Current Applications
61. Interfacial and colloidal characterization of oil-in-water emulsions stabilized by interface-tunable solid lipid nanoparticles10.1016/j.foodchem.2019.125619 ↗
62. Pickering emulsions in foods - opportunities and limitations10.1080/10408398.2017.1290578 ↗
63. New fundamental concepts in emulsion rheology10.1016/S1359-0294(99)00035-7 ↗
64. Electron microscopy of nanoemulsions: an essential tool for characterisation and stability assessment10.1016/j.micron.2011.07.014 ↗
65. Imaging of self-assembled structures: interpretation of TEM and cryo-TEM images10.1002/anie.201001493 ↗
66. Negative staining across holes: application to fibril and tubular structures10.1016/j.micron.2007.07.003 ↗
67. DLS and zeta potential - What they are and what they are not?10.1016/j.jconrel.2016.06.017 ↗
68. Tumor-targeting intravenous lipid emulsion of paclitaxel: Characteristics, stability, toxicity, and toxicokinetics10.1016/j.jpha.2022.08.002 ↗
69. The pH of the digestive vacuole of Plasmodium falciparum is not associated with chloroquine resistance10.1242/jcs.02795 ↗
70. Mechanistic insights into the intracellular release of doxorubicin from pH-sensitive liposomes10.1016/j.biopha.2020.110952 ↗
71. A review of mechanistic insight and application of pH-sensitive liposomes in drug delivery10.3109/10717544.2014.882469 ↗
72. Nanotechnology applied to the treatment of malaria10.1016/j.addr.2009.11.024 ↗
73. Antipsychotics-Loaded Nanometric Emulsions for Brain Delivery10.3390/pharmaceutics14102174 ↗
74. Characterization and stability evaluation of β-carotene nanoemulsions prepared by high pressure homogenization under various emulsifying conditions10.1016/j.foodres.2007.09.006 ↗
75. Nanoparticles for drug delivery in cancer treatment10.1016/j.urolonc.2007.03.015 ↗
76. Biotin-functionalized copolymeric PEG-PCL micelles for in vivo tumour-targeted delivery of artemisinin10.1080/21691401.2018.1543199 ↗
77. Biological Model Systems for the Testing of the Toxicity of Biomaterials
78. Transferrin mediated solid lipid nanoparticles containing curcumin: Enhanced in vitro anticancer activity by induction of apoptosis
79. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique10.1128/AAC.16.6.710 ↗
80. Artemisinin-Resistant Malaria in Asia10.1056/NEJMc0900231 ↗
81. Short-chain aliphatic polysulfonates inhibit the entry of Plasmodium into red blood cells10.1128/AAC.46.8.2619-2626.2002 ↗
82. Solute transport via the new permeability pathways in Plasmodium falciparum-infected human red blood cells is not consistent with a simple single-channel model10.1182/blood-2006-02-001693 ↗